Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 48

1.

A protocol for a randomised, double-blind, placebo-controlled study of the effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes (The LIVE Study).

Jorsal A, Wiggers H, Holmager P, Nilsson B, Nielsen R, Boesgaard TW, Kumme A, Møller JE, Videbæk L, Kistorp C, Gustafsson I, Tarnow L, Flyvbjerg A.

BMJ Open. 2014 May 20;4(5):e004885. doi: 10.1136/bmjopen-2014-004885.

PMID:
24844271
[PubMed - in process]
Free PMC Article
2.

[Dopamin agonist treatment and fibrotic heart valve disease in hyperprolactinaemia patients.]

Steffensen C, Mægbæk ML, Laurberg P, Andersen M, Kistorp C, Nørrelund H, Dal J, Jørgensen JO.

Ugeskr Laeger. 2014 Jan 6;176(1). pii: V12120725. Danish.

PMID:
24629610
[PubMed - as supplied by publisher]
3.

Investigating the causal effect of vitamin D on serum adiponectin using a mendelian randomization approach.

Husemoen LL, Skaaby T, Martinussen T, Jørgensen T, Thuesen BH, Kistorp C, Jeppesen J, Thyssen JP, Meldgaard M, Szecsi PB, Fenger M, Linneberg A.

Eur J Clin Nutr. 2014 Feb;68(2):189-95. doi: 10.1038/ejcn.2013.233. Epub 2013 Nov 13.

PMID:
24219894
[PubMed - in process]
4.

Prognostic significance of cardiovascular biomarkers and renal dysfunction in outpatients with systolic heart failure: a long term follow-up study.

Bosselmann H, Egstrup M, Rossing K, Gustafsson I, Gustafsson F, Tonder N, Kistorp CN, Goetze JP, Schou M.

Int J Cardiol. 2013 Dec 10;170(2):202-7. doi: 10.1016/j.ijcard.2013.10.064. Epub 2013 Oct 26.

PMID:
24182673
[PubMed - indexed for MEDLINE]
5.

Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study.

Christensen HM, Kistorp C, Schou M, Keller N, Zerahn B, Frystyk J, Flyvbjerg A, Faber J.

Metabolism. 2014 Jan;63(1):141-9. doi: 10.1016/j.metabol.2013.09.017. Epub 2013 Oct 17.

PMID:
24140097
[PubMed - indexed for MEDLINE]
6.

Body mass index in chronic heart failure: association with biomarkers of neurohormonal activation, inflammation and endothelial dysfunction.

Christensen HM, Schou M, Goetze JP, Faber J, Frystyk J, Flyvbjerg A, Kistorp C.

BMC Cardiovasc Disord. 2013 Oct 1;13:80. doi: 10.1186/1471-2261-13-80.

PMID:
24083942
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Copeptin during rest and exercise in major depression.

Krogh J, Gøtze JP, Jørgensen MB, Kristensen LØ, Kistorp C, Nordentoft M.

J Affect Disord. 2013 Oct;151(1):284-90. doi: 10.1016/j.jad.2013.06.007. Epub 2013 Jul 13.

PMID:
23856279
[PubMed - indexed for MEDLINE]
8.

Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status.

Christensen HM, Kistorp C, Schou M, Keller N, Zerahn B, Frystyk J, Schwarz P, Faber J.

Endocrine. 2013 Jun;43(3):626-34. doi: 10.1007/s12020-012-9836-3. Epub 2012 Nov 22.

PMID:
23179776
[PubMed - indexed for MEDLINE]
9.

Haemodynamic response during low-dose dobutamine infusion in patients with chronic systolic heart failure: comparison of echocardiographic and invasive measurements.

Egstrup M, Gustafsson I, Andersen MJ, Kistorp CN, Schou M, Tuxen CD, Møller JE.

Eur Heart J Cardiovasc Imaging. 2013 Jul;14(7):659-67. doi: 10.1093/ehjci/jes234. Epub 2012 Nov 6.

PMID:
23136446
[PubMed - indexed for MEDLINE]
10.

Abnormal glucose metabolism is associated with reduced left ventricular contractile reserve and exercise intolerance in patients with chronic heart failure.

Egstrup M, Kistorp CN, Schou M, Høfsten DE, Møller JE, Tuxen CD, Gustafsson I.

Eur Heart J Cardiovasc Imaging. 2013 Apr;14(4):349-57. doi: 10.1093/ehjci/jes165. Epub 2012 Aug 16.

PMID:
22898711
[PubMed - indexed for MEDLINE]
11.

Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure.

Egstrup M, Schou M, Tuxen CD, Kistorp CN, Hildebrandt PR, Gustafsson F, Faber J, Goetze JP, Gustafsson I.

Am J Cardiol. 2012 Aug 15;110(4):552-7. doi: 10.1016/j.amjcard.2012.04.033. Epub 2012 May 10.

PMID:
22579083
[PubMed - indexed for MEDLINE]
12.

Plasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic doses.

Balling L, Kistorp C, Schou M, Egstrup M, Gustafsson I, Goetze JP, Hildebrandt P, Gustafsson F.

J Card Fail. 2012 May;18(5):351-8. doi: 10.1016/j.cardfail.2012.01.019. Epub 2012 Mar 10.

PMID:
22555263
[PubMed - indexed for MEDLINE]
13.

Heart valve disease among patients with hyperprolactinemia: a nationwide population-based cohort study.

Steffensen C, Maegbaek ML, Laurberg P, Andersen M, Kistorp CM, Norrelund H, Sørensen HT, Jorgensen JO.

J Clin Endocrinol Metab. 2012 May;97(5):1629-34. doi: 10.1210/jc.2011-3257. Epub 2012 Mar 14.

PMID:
22419729
[PubMed - indexed for MEDLINE]
14.

α-Defensins and outcome in patients with chronic heart failure.

Christensen HM, Frystyk J, Faber J, Schou M, Flyvbjerg A, Hildebrandt P, Raymond I, Klausen TW, Kistorp C.

Eur J Heart Fail. 2012 Apr;14(4):387-94. doi: 10.1093/eurjhf/hfs021. Epub 2012 Feb 22.

PMID:
22357441
[PubMed - indexed for MEDLINE]
15.

Plasma calprotectin levels reflect disease severity in patients with chronic heart failure.

Jensen LJ, Kistorp C, Bjerre M, Raymond I, Flyvbjerg A.

Eur J Prev Cardiol. 2012 Oct;19(5):999-1004. doi: 10.1177/1741826711421078. Epub 2011 Sep 2.

PMID:
21890535
[PubMed - indexed for MEDLINE]
16.

Cardiovascular events in thyroid disease: a population based, prospective study.

Schultz M, Kistorp C, Raymond I, Dimsits J, Tuxen C, Hildebrandt P, Faber J.

Horm Metab Res. 2011 Aug;43(9):653-9. doi: 10.1055/s-0031-1283162. Epub 2011 Aug 5.

PMID:
21823062
[PubMed - indexed for MEDLINE]
17.

Oral glucose tolerance testing in an outpatient heart failure clinic reveals a high proportion of undiagnosed diabetic patients with an adverse prognosis.

Egstrup M, Schou M, Gustafsson I, Kistorp CN, Hildebrandt PR, Tuxen CD.

Eur J Heart Fail. 2011 Mar;13(3):319-26. doi: 10.1093/eurjhf/hfq216. Epub 2010 Dec 8.

PMID:
21148170
[PubMed - indexed for MEDLINE]
18.

Complement activation, endothelial dysfunction, insulin resistance and chronic heart failure.

Bjerre M, Kistorp C, Hansen TK, Faber J, Lip GY, Hildebrandt P, Flyvbjerg A.

Scand Cardiovasc J. 2010 Oct;44(5):260-6. doi: 10.3109/14017431.2010.484506. Epub 2010 Jun 7.

PMID:
20524927
[PubMed - indexed for MEDLINE]
19.

Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population.

Andreassen M, Raymond I, Hildebrandt P, Kistorp C, Rathcke C, Vestergaard H, Faber J, Kristensen LO.

Inflamm Res. 2010 Jul;59(7):503-10. doi: 10.1007/s00011-009-0154-z. Epub 2010 Jan 3.

PMID:
20047081
[PubMed - indexed for MEDLINE]
20.

Plasma YKL-40 levels are elevated in patients with chronic heart failure.

Rathcke CN, Kistorp C, Raymond I, Hildebrandt P, Gustafsson F, Lip GY, Faber J, Vestergaard H.

Scand Cardiovasc J. 2010 Apr;44(2):92-9. doi: 10.3109/14017430903402218.

PMID:
19961288
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk